Showing results (101-110 of 831) with videos related to

Sort By:
Pageof 84
Seminars in Hematology|February 13, 2007
New targeted therapies for chronic myelogenous leukemia: opportunities to overcome imatinib resistanceElias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Future Oncology (London, England)|August 2, 2013
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemiaCourtney D DiNardo, Susan O'Brien, Varsha V Gandhi, et al.
Seminars in Hematology|November 20, 2013
Targeted therapies in hematology and their impact on patient care: chronic and acute myeloid leukemiaElias Jabbour, Jorge Cortes, Farhad Ravandi, et al.
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyondElias Jabbour, Jorge Cortes, Francis Giles, et al.
British Journal of Haematology|January 22, 2023
How we approach the perioperative management of patients with chronic lymphocytic leukaemia receiving continuous cancer-directed therapiesHelen Ma, Stephani Wang, Susan O'Brien, et al.
Pediatric Blood & Cancer|September 4, 2013
Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemiaMichael Rytting, Lisa Triche, Deborah Thomas, et al.
Expert Review of Hematology|November 13, 2014
Ibrutinib: a paradigm shift in management of CLLTalha Badar, Jan A Burger, William G Wierda, et al.
ACS Biomaterials Science & Engineering|July 23, 2025
Micropocket-Based Differentiation System to Streamline and Scale Stem Cell-Derived Pancreatic Islet ProductionSusan O'Brien, Chen Li, Rusvir Trana, et al.
Diagnostic Pathology|April 22, 2008
Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidenceJohn L Frater, Neil E Kay, Charles L Goolsby, et al.
Leukemia & Lymphoma|May 19, 2016
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cellsNeil E Kay, Traci Sassoon, Charla Secreto, et al.
Pageof 84